Multiparameter Patient Monitoring Systems Market (2025 - 2033) Size, Share & Trends Analysis Report By Device (Fixed, Portable), By Acuity Level (High, Medium, Low), By Age Group (Pediatric, Adult), By End Use, By Region, And Segment Forecasts

Multiparameter Patient Monitoring Systems Market Summary

The global multiparameter patient monitoring systems market size was estimated at USD 12.90 billion in 2024 and is projected to reach USD 21.42 billion by 2033, growing at a CAGR of 5.82% from 2025 to 2033. The market growth is primarily driven by the increasing demand for early diagnosis and treatment of chronic illnesses, the growing need for real-time patient monitors in critical care units, utilizing data points for enhanced clinical decisions, and providing hospital-like care in home care settings.

Inpatient wards and intensive care units (ICU) use multiparameter patient monitors to improve the patient's quality of life. Multiparameter monitoring is an essential part of the care of critically ill patients, especially in emergency departments, as the functional response to critical illness is strongly linked to the outcome. For instance, according to the CDC's National Center for Health Statistics, around 155.4 million people visited emergency departments in the U.S. in 2024. Monitoring critically ill patients using multiparameter monitors allows the measurement of physiological reserves and indicates the effectiveness of therapeutic interventions.

Moreover, the introduction of wireless networks such as radio frequency identification (RFID) and medical body area networks (MBAN) in the healthcare sector has revolutionized the diagnostic processes of patient health without causing any discomfort attributed to its wireless design. This aids in monitoring heart rate, blood pressure, body temperature, and oxygen level. Furthermore, key strategic developments undertaken by multiparameter patient monitoring participants are anticipated to propel growth further. For instance, in June 2023, Royal Philips and Masimo announced FDA approval to integrate SedLine brain functioning monitoring, regional oximetry, and CO2 measurements with IntelliVue MX750 and MX850. The integration is expected to allow clinicians to assess blood saturation of the brain, anesthetic sedation, and other key factors within the same monitor.

Advancements in wearable devices and wireless communication technology for medical telemetry have further increased the scope of multiparameter monitoring solutions for patient’s inside and outside hospital premises. Such technological advancements enable the recording and transmission of data instantly from a patient’s device to a healthcare professional, decreasing the evaluation and treatment duration. For instance, in December 2022, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched mWear to monitor six vital signs and integrate home-based care.

Recent Developments in Multiparameter Patient Monitoring Systems Market

Market Concentration & Characteristics

The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, level of partnerships & collaboration activities, degree of innovation, impact of regulations, and regional expansion. The market for multiparameter patient monitoring systems is fragmented, with the presence of several emerging players entering the market. The degree of innovation is high. The level of merger & acquisition activities is moderate. The impact of regulations on industry and the regional expansion of industry is high.

The multiparameter patient monitoring systems industry experiences a high degree of innovation driven by technological advancements. The increasing adoption of artificial intelligence in smart health monitoring devices supports new innovations in the market. For instance, in June  2024, Star Health Insurance launched the AI-driven Star Health Face Scan tool for remote health assessment. This innovative feature provides instant analysis of 18 vital health parameters, including blood pressure, heart rate, and hemoglobin, via a simple face scan.

The industry is experiencing a moderate level of merger and acquisition activities undertaken by several key players. This is due to the desire to gain a competitive advantage in the industry, enhance technological capabilities, and consolidate in a rapidly growing market.

Regulations, such as the HIPAA in the U.S. and the GDPR in Europe, establish standards for safeguarding patient data privacy and security. Compliance with these regulations is crucial for AI applications in healthcare to ensure the safe and secure handling of patient information, reducing the risk of data breaches and unauthorized access.

The industry is witnessing high geographical expansion. Companies within the multiparameter patient monitoring systems industry seek geographic expansion strategies to maintain their foothold in emerging markets and attract customers from these regions. With the growing adoption of digital healthcare solutions, the market is expected to grow significantly in the coming years, especially in developing and underdeveloped countries. For instance, in April 2024, Dräger launched its Vista 300 patient monitoring system in India. Advanced parameters include three invasive blood pressures, flexible etCO2 measurement, cardiac output, and the capacity to add modules like SCIO, CO2, BIS, Masimo, or Nellcor SpO2. This system is designed to enhance hospital-wide information flow by enabling continuous, end-to-end data transfer from the patient’s bedside directly to the Hospital Information System (HIS). This integration ensures that critical clinical data is accessible across departments, supporting care delivery from the Emergency Room (ER) to the Intensive Care Unit (ICU) and Neonatal Intensive Care Unit (NICU).

Integration of Artificial Intelligence (AI) in Multiparameter Patient Monitoring Systems

Integrating Artificial Intelligence (AI) into multiparameter patient monitoring systems represents a significant advancement in how patient health data is collected, analyzed, and utilized. Traditionally, these systems monitor key vital signs such as heart rate, blood pressure, oxygen saturation, and respiratory rate. AI algorithms are able to analyze real-time data continuously, identify patterns, and detect early warning signs of patient deterioration.  AI-powered monitoring systems provide alerts for potential complications like sepsis, cardiac arrest, or respiratory failure. In addition, AI can support predictive analytics, helping hospitals identify high-risk patients and prioritize care.

Furthermore, hospitals increasingly seek devices that deliver actionable insights and remote monitoring capabilities, especially for chronic care and post-discharge patients. For instance, in November 2024, LifeSignals received FDA Class II 510(k) clearance for its UbiqVue 2A Multiparameter System. This represents a significant advancement in continuous wireless patient monitoring across hospital and out-of-hospital settings. The system centers on a single-use, wearable biosensor that is chest-mounted and continuously monitors multiple physiological parameters, including chest-based SpO₂, 2-channel ECG, Pulse rate, PPG waveform, respiration rate, body (core) and skin temperature, motion, and posture. 

"It shows our commitment to the vision of expanding the UbiqVue system with additional vital signs and advanced AI capabilities. Through global partnerships with OEMs, service providers, IDTFs, and distributors, we aim to transform healthcare at scale."

-Surendar Magar, Co-founder and CEO

Thus, as healthcare providers increasingly prioritize predictive care, operational efficiency, and patient safety, the demand for intelligent, AI-enabled monitors is expected to rise significantly.

Device Insights

Based on device, the portable devices segment held the largest market share of 66.81% in 2024. In addition, this segment is expected to grow at the fastest CAGR during the forecast period. This is attributed to various advantages offered by portable systems, including lightweight design for easy transportation. Portable multiparameter patient monitoring systems offer easy mobility across different departments within and outside the hospital. The portable systems or devices are technologically advanced products that incorporate digital technology and the ubiquity of smartphones with wireless connectivity and cloud integration. In addition, they come in a wearable form that offers greater mobility to patients and can be used in any environment, including homecare settings. For instance, in May 2025, Medtronic expanded its Acute Care & Monitoring portfolio in Europe through a new distribution agreement for the Corsano multi-parameter wearable. The Corsano multi-parameter wearable is a medically certified device designed for continuous, non-invasive monitoring of vital signs, including heart rate, respiratory rate, SpO₂, cuffless blood pressure, and ECG. This innovation enables seamless real-time data access, supporting hospital and hospital-at-home care.

“Our mission at Corsano Health is to transform healthcare by delivering actionable insights that enhance patient outcomes-seamlessly, from hospital to home. Through this innovation, we aim to empower clinicians with advanced remote monitoring capabilities to simplify workflows and provide proactive care. Together, we are redefining connected care models to support the evolving needs of healthcare systems, addressing workforce shortages while enabling personalized and efficient patient management at every stage of care.”

-Corsano Health’s CEO, Peter Stas

Acuity Level Insights

Based on acuity level, the high acuity segment accounted for the largest revenue share of 45.77% in 2024. This is attributed to the ability to store patient data and advanced connectivity options. Furthermore, high-acuity patients include those with acute life-threatening conditions and the need for continuous monitoring with cautious treatment. These patients are often admitted to critical care units such as ICUs, neonatal care units NCUs, and cardiac care units CCUs. For instance, in June 2023, Philips and Masimo announced new advanced monitoring capabilities for Philips' high acuity patient monitors, including SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO₂ monitoring.  This integration enables clinicians to assess cerebral oxygenation, anesthetic sedation, and respiratory performance from a single monitor without additional equipment. 

The low-acuity multiparameter patient monitoring systems segment is expected to witness the fastest CAGR over the forecast period. Low-acuity patients have relatively stable medical conditions and require minimal monitoring and medical interventions. Moreover, the growing number of minimally invasive surgeries (MIS) worldwide is expected to provide marketable opportunities. 

Age Group Insights

Based on age group, the geriatric segment accounted for the highest revenue share of 54.19% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The dominant share is owing to the higher prevalence of chronic disease in the elderly, which requires continuous patient monitoring. For instance, according to the World Health Organization, an estimated 1.28 billion adults (aged 30-79 years) are currently living with hypertension. In addition, cardiovascular disorders (CVDs) are the leading cause of death globally, causing an estimated 17.9 million deaths each year. In addition, according to Alzheimer’s Disease International, the global dementia prevalence is expected to reach 78 million in 2030 and 139 million in 2050.

Moreover, the pediatric segment is anticipated to grow significantly over the forecast period. Neonates and pediatric patients are especially vulnerable to sudden physiological changes, requiring constant and precise monitoring of vital signs such as heart rate, respiration, oxygen saturation, and temperature. As pediatric hospital admissions increase, especially in neonatal intensive care units (NICUs) and pediatric intensive care units (PICUs), the demand for dedicated multiparameter monitors continues to rise.

End Use Insights

Based on end use, the hospitals segment held the largest share of 40.76% in 2024. This is attributed to the increasing number of patients admitted to hospitals due to chronic diseases, injuries, and other emergencies. Multiparameter patient monitors are widely used in general wards and ICUs to continuously monitor patients’ health based on various human vital parameters such as oxygen saturation, respiration rate, blood pressure, and heart rate.

The homecare settings segment is expected to witness the fastest CAGR over the forecast period. Multiparameter patient monitoring systems also assist with medication management in a home care setting. Furthermore, secure communication channels allow patients to interact with healthcare providers. For instance, in August 2022, Medtronic partnered with BioIntelliSense, Inc. to distribute multiparameter wearables for patient monitoring applications in hospital and homecare settings.

Regional Insights

North America multiparameter patient monitoring systems industry accounted for the largest regional revenue share of 43.12% in 2024. This is attributed to the advanced healthcare infrastructure and strong reimbursement frameworks that support the widespread adoption of monitoring technologies across hospitals and outpatient settings. The growing demand for home-based care and remote patient monitoring (RPM) is also contributing to market expansion.

U.S. Multiparameter Patient Monitoring Systems Market Trends

The U.S. multiparameter patient monitoring systems industry held the largest market share in 2024 in the North American region. The country experiences strong integration of AI and IoT technologies into patient monitoring platforms, driven by tech-heavy healthcare startups and established device manufacturers. For instance, in October 2024, Netherlands-based startup Lapsi Health launched Keikku, a portable, wireless digital stethoscope in the U.S. The device uses AI and sensing technology to capture body sounds like breathing and convert them into data-driven insights. Keikku enables sharing, streaming, cropping, and annotating sound clips via its app and web platform, enhancing diagnostics for respiratory, cardiac, and gastrointestinal conditions.

“We are making auscultation available for in-home monitoring with clear results for you to be able to know when to contact your healthcare provider, just as the thermometer.”

-Diana van Stijn, chief medical officer at Lapsi Health

Europe Multiparameter Patient Monitoring Systems Market Trends

The multiparameter patient monitoring systems industry in Europe is expected to witness significant growth during the forecast period. The increasing burden of aging populations, especially in countries such as Italy, Germany, and France, creates a steady demand for monitoring systems to manage acute and long-term care patients. For instance, in April 2024, Royal Philips and smartQare announced a strategic partnership to integrate smartQare’s viQtor solution with Philips’ clinical patient monitoring platforms. The partnership aims to transform continuous patient monitoring both inside and outside hospitals in Europe. Moreover, integrating 5G with healthcare drives Europe's market by enabling faster, more reliable connectivity for advanced medical technologies.

The UK multiparameter patient monitoring systems industry is expected to grow over the forecast period, owing to the rapid technological advances, widespread adoption of wearable and remote monitoring devices, and an increasing need for continuous healthcare delivery outside traditional settings. In addition, the NHS's promotion of digital health solutions has increased the acceptance and adoption of smart health devices among healthcare providers and patients, thus fueling market growth further. 

The multiparameter patient monitoring systems industry in Germany held the largest market share in 2024. This is attributed to the increasing investments in healthcare technology and robust infrastructure. In addition, favorable government initiatives and insurance coverage, coupled with the integration of artificial intelligence, IoT, and telemedicine platforms, accelerate efficient and accurate patient care across healthcare facilities.   

Asia Pacific Multiparameter Patient Monitoring Systems Market Trends

Asia Pacific multiparameter patient monitoring systems industry is projected to experience the fastest CAGR in the coming years. This growth is attributed to the rising prevalence of chronic diseases, rapid digital transformation, and increasing investment in health tech. Furthermore, the high penetration of smartphones and wearable devices and increasing health literacy enhance the demand for AI-integrated health tools.

India multiparameter patient monitoring systems industryis expanding rapidly, driven by the high prevalence of chronic diseases, government health initiatives, and technological innovation. For instance, according to a study published in the BMC Journal in October 2024, the overall prevalence of hypertension in India is found to be 22.6%. Moreover, the Digital India campaign encourages the adoption of digital technologies in healthcare, supporting the integration of AI in monitoring devices. Furthermore, the market is experiencing a growing adoption of AI technologies by healthcare providers in the country. In September 2021, Medtronic India partnered with Stasis Health Private Limited, a subsidiary of Stasis Labs, to scale and expand access to the Stasis Monitor, a connected care bedside multi-parameter patient monitoring system in India. 

Multiparameter patient monitoring systems industry in Japan is expected to grow rapidly, owing to the growing geriatric population, increasing healthcare expenditure, and rapid adoption of artificial intelligence in healthcare. Moreover, increasing public and private funding, coupled with the rapid adoption of telehealth solutions are expected to propel market growth further.

Latin America Multiparameter Patient Monitoring Systems Market Trends

The multiparameter patient monitoring systems industry in Latin America is anticipated to grow at a significant CAGR over the forecast period. This is attributed to the growing awareness about AI technologies, increasing government spending, and growing advancements in healthcare infrastructure.

Middle East and Africa Multiparameter Patient Monitoring Systems Market Trends

The Middle East and Africa multiparameter patient monitoring systems industry is expected to grow at a significant CAGR over the forecast period. The market is characterized by a dynamic landscape driven by the growing adoption of smart medical devices, increasing healthcare expenditures, and supportive government policies. Significant integration of AI in healthcare technology across the region contributes to market growth further. Countries such as Saudi Arabia and the UAE are integrating AI into healthcare infrastructure under strategic visions such as Saudi Vision 2030 and the UAE National Strategy for Artificial Intelligence 2031.

The multiparameter patient monitoring systems industry in Saudi Arabia is expected to grow rapidly, owing to the rapid adoption of artificial intelligence in healthcare. In addition, favorable government support, coupled with the adoption of telehealth initiatives, propels market growth further. For instance, the Seha Virtual Hospital is a telehealth platform leveraging AI, augmenting reality, digital twins, and remote diagnostics. It connects over 224 hospitals across the Kingdom to offer medical services to its citizens.

Key Multiparameter Patient Monitoring Systems Company Insights

Key players operating in the multiparameter patient monitoring systems industry are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as new product launches and partnerships play a key role in propelling market growth.

Recent Developments

• In May 2025, Hyderabad-based Niloufer Hospital launched AmruthSwasthBharath, an AI-based diagnostic tool for non-invasive blood testing. This device provides results in under a minute, utilizing Remote Photoplethysmography (PPG) to measure key health parameters such as blood pressure, heart rate, SpO2, respiration rate, and hemoglobin A1c via smartphones.

• In February 2025, Validic launched a generative AI-powered assistant for remote patient monitoring (RPM) using generative AI (GenAI) within its Validic Impact platform. Utilizing Generative AI, the solution automatically analyzes variations in vital health metrics such as blood glucose levels, blood pressure, medication adherence, and lifestyle factors, delivering clinicians’ insights between patient evaluations.

• In April 2023, Royal Philips and Northwell Health entered a seven-year agreement to standardize and future-proof patient monitoring across Northwell’s extensive healthcare enterprise, which includes 21 hospitals and 850 outpatient facilities serving over two million patients annually. 

• In October 2023, Royal Philips launched the Visual Patient Avatar, an innovative patient monitoring solution that transforms complex vital sign data into an easy-to-understand visual avatar, improving situational awareness and decision-making in operating rooms. 

• In June 2023, Masimo’s Radius VSM, a patient-worn, continuous multi-parameter vital signs monitor, received FDA 510(k) clearance. It is designed on a modular platform and monitors various physiological parameters, including Masimo SET pulse oximetry, noninvasive blood pressure, temperature, respiration rate, and ECG. The wearable device combines the accuracy of larger bedside monitors with patient mobility, allowing continuous monitoring during ambulation.

• In October 2022, Nihon Kohden released the Life Scope G7 patient monitor in the U.S. market. The device is designed specifically for high-acuity settings and features a 19-inch screen, offering quick access to multiple configurations and trend analysis.

• In August 2022, Medtronic partnered with BioIntelliSense for exclusive U.S. distribution of the BioButton multi-parameter wearable device, designed for continuous remote patient monitoring from in-hospital to home settings. The medical-grade BioButton can record up to 1,440 vital sign measurements daily, including skin temperature, respiratory rate, and heart rate at rest.

Multiparameter Patient Monitoring Systems Market Report Scope

Global Multiparameter Patient Monitoring Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global multiparameter patient monitoring systems market report based on device, acuity level, age group, end use, and region:

• Device Outlook (Revenue, USD Million, 2021 - 2033)

  • Portable

  • Fixed

• Acuity Level Outlook (Revenue, USD Million, 2021 - 2033)

  • High

  • Medium

  • Low

• Age Group Outlook (Revenue, USD Million, 2021 - 2033)

  • Pediatric

  • Adult

  • Geriatric

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Home Care Settings

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait